Literature DB >> 20846677

Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy.

Sergey Shikanov1, Melanie A Clark, Jay D Raman, Benjamin Smith, Matthew Kaag, Paul Russo, Jeffrey C Wheat, J Stuart Wolf, William C Huang, Arieh L Shalhav, Scott E Eggener.   

Abstract

PURPOSE: A novel equation, the Chronic Kidney Disease Epidemiology Collaboration, has been proposed to replace the Modification of Diet in Renal Disease for estimated glomerular filtration rate due to higher accuracy, particularly in the setting of normal renal function. We compared these equations in patients with 2 functioning kidneys undergoing partial nephrectomy.
MATERIALS AND METHODS: We assembled a cohort of 1,158 patients from 5 institutions who underwent partial nephrectomy between 1991 and 2009. Only subjects with 2 functioning kidneys were included in the study. The end points were baseline estimated glomerular filtration rate, last followup estimated glomerular filtration rate (3 to 18 months), absolute and percent change estimated glomerular filtration rate ([absolute change/baseline] × 100%), and proportion of newly developed chronic kidney disease stage III. The agreement between the equations was evaluated using Bland-Altman plots and the McNemar test for paired observations.
RESULTS: Mean baseline estimated glomerular filtration rate derived from the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration equations were 73 and 77 ml/minute/1.73 m(2), respectively, and following surgery were 63 and 67 ml/minute/1.73 m(2), respectively. Mean percent change estimated glomerular filtration rate was -12% for both equations (p = 0.2). The proportion of patients with newly developed chronic kidney disease stage III following surgery was 32% and 25%, according to the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration equations, respectively (p = 0.001).
CONCLUSIONS: For patients with 2 functioning kidneys undergoing partial nephrectomy the Chronic Kidney Disease Epidemiology Collaboration equation provides slightly higher glomerular filtration rate estimates compared to the Modification of Diet in Renal Disease equation, with 7% fewer patients categorized as having chronic kidney disease stage III or worse.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20846677     DOI: 10.1016/j.juro.2010.06.104

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Preoperative Renal Volume: A Surrogate Measure for Radical Nephrectomy-Induced Chronic Kidney Disease.

Authors:  Fiona Mei Wen Wu; Melissa Hui Wen Tay; Bee Choo Tai; Zhaojin Chen; Lincoln Tan; Benjamin Yen Seow Goh; Lata Raman; Ho Yee Tiong
Journal:  J Endourol       Date:  2015-09-09       Impact factor: 2.942

2.  New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors.

Authors:  Joseph W Mashni; Melissa Assel; Alexandra Maschino; Mary Russo; Brendan Masi; Melanie Bernstein; William C Huang; Paul Russo
Journal:  Urology       Date:  2015-09-08       Impact factor: 2.649

3.  Prevalence and Clinical Significance of Low T3 Syndrome in Non-Dialysis Patients with Chronic Kidney Disease.

Authors:  Jingxian Fan; Peng Yan; Yingdeng Wang; Bo Shen; Feng Ding; Yingli Liu
Journal:  Med Sci Monit       Date:  2016-04-08

4.  Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer.

Authors:  Jan Ebbing; Felix Menzel; Paolo Frumento; Kurt Miller; Bernhard Ralla; Tom Florian Fuller; Jonas Busch; Justin William Collins; Christofer Adding; Hans Helge Seifert; Peter Ardelt; Christian Wetterauer; Timm Westhoff; Carsten Kempkensteffen
Journal:  BMC Nephrol       Date:  2019-02-04       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.